Renal mass reduction increases the response to exogenous insulin independent of acid-base status or plasma insulin levels in rats
- PMID: 34396787
- PMCID: PMC8560408
- DOI: 10.1152/ajprenal.00679.2020
Renal mass reduction increases the response to exogenous insulin independent of acid-base status or plasma insulin levels in rats
Abstract
Impairments in insulin sensitivity can occur in patients with chronic kidney disease (CKD). Correction of metabolic acidosis has been associated with improved insulin sensitivity in CKD, suggesting that metabolic acidosis may directly promote insulin resistance. Despite this, the effect of acid or alkali loading on insulin sensitivity in a rodent model of CKD (remnant kidney) has not been directly investigated. Such studies could better define the relationship between blood pH and insulin sensitivity. We hypothesized that in remnant kidney rats, acid or alkali loading would promote loss of pH homeostasis and consequently decrease insulin sensitivity. To test this hypothesis, we determined the impact of alkali (2 wk) or acid (5-7 days) loading on plasma electrolytes, acid-base balance, and insulin sensitivity in either sham control rats, 2/3 nephrectomized rats, or 5/6 nephrectomized rats. Rats with 5/6 nephrectomy had the greatest response to insulin followed by rats with 2/3 nephrectomy and sham control rats. We found that treatment with 0.1 M sodium bicarbonate solution in drinking water had no effect on insulin sensitivity. Acid loading with 0.1 M ammonium chloride resulted in significant reductions in pH and plasma bicarbonate. However, acidosis did not significantly impair insulin sensitivity. Similar effects were observed in Zucker obese rats with 5/6 nephrectomy. The effect of renal mass reduction on insulin sensitivity could not be explained by reduced insulin clearance or increased plasma insulin levels. We found that renal mass reduction alone increases sensitivity to exogenous insulin in rats and that this is not acutely reversed by the development of acidosis.NEW & NOTEWORTHY Impairments in insulin sensitivity can occur in patients with chronic kidney disease, and previous work has suggested that metabolic acidosis may be the underlying cause. Our study investigated the effect of acid or alkali loading on insulin sensitivity in a rodent model of chronic kidney disease. We found that renal mass reduction increases the blood glucose response to insulin and that this is not acutely reversed by the development of acidosis.
Keywords: Zucker obese rat; blood glucose; chronic kidney disease; insulin resistance; metabolic acidosis.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Figures







References
-
- Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13: 1894–1900, 2002. doi:10.1097/01.asn.0000019900.87535.43. - DOI - PubMed
-
- Gilbert RE, Mann JF, Hanefeld M, Spinas G, Bosch J, Yusuf S, Gerstein HC; The ORIGIN Trial Investigators. Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the outcome reduction with an initial glargine intervention (ORIGIN) trial. Diabetologia 57: 1325–1331, 2014. doi:10.1007/s00125-014-3238-4. - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- R15 HL154067/HL/NHLBI NIH HHS/United States
- R21 AI150723/AI/NIAID NIH HHS/United States
- P01 HL134604/HL/NHLBI NIH HHS/United States
- HL134604/HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- AI150723/Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
LinkOut - more resources
Full Text Sources
Medical